Rare diseases
Investigational molecules
Locations
Back to Poland45 clinical trials in Chrzanow, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
PolandStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
PolandPolandStudy on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen
PolandStudy on Metformin's Effect in Reducing Unplanned Heart Procedures in Non-Diabetic Patients with Acute Coronary Syndrome
PolandStudy on the Effects of Ferric Carboxymaltose on Heart Health and Quality of Life in Patients with Recent Heart Attack and Iron Deficiency
PolandA study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
PolandPhase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs
PolandEfficacy and Safety of BAY 3670549 in Adults with Atrial Fibrillation: A Randomized, Double‑Blind, Placebo‑Controlled Phase 2 Study
PolandStudy of AP31969 compared to placebo to control heart rhythm in patients with atrial fibrillation
PolandStudy of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
PolandPolandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on heart failure treatment and prevention, including studies of innovative therapies like baxdrostat and dapagliflozin combinations. Research encompasses both acute and chronic conditions.
Multiple studies are evaluating novel approaches to reduce major cardiovascular events and improve patient outcomes.
Clinical investigations targeting chronic obstructive pulmonary disease and severe viral lung infections, with emphasis on testing new therapeutic agents like tezepelumab and tozorakimab.
Research focuses on improving breathing function and reducing disease exacerbations.
Advanced research in chronic kidney disease treatment, including combination therapy trials and studies on preventing surgery-associated kidney injury.
Studies aim to slow disease progression and improve outcomes in patients with kidney conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
